Pancreatic cancer-associated Cathepsin e as a drug activator

Journal of Controlled Release

Volumn 167, Issue 3, 2013, Pages 221-227

  Abd Elgaliel, Wael R ^a   Cruz Monserrate, Zobeida ^b   Wang, Huamin ^b   Logsdon, Craig D ^b   Tung, Ching Hsuan ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

5 Aminolevulinic acid; Cathepsin E; Drug activation; Pancreatic cancer; Photodynamic therapy; Prodrug

Indexed keywords

5-AMINOLEVULINIC ACID; 5-AMINOLEVULINIC ACID (5-ALA); ACTIVATION APPROACHES; CATHEPSIN E; DUCTAL ADENOCARCINOMAS; PANCREATIC CANCERS; PHOTODYNAMIC THERAPY (PDT); PRODRUGS;

CELL DEATH; DISEASES; GENETIC ENGINEERING; HISTOLOGY; PHOTODYNAMIC THERAPY; TUMORS;

CHEMICAL ACTIVATION;

AMINOLEVULINIC ACID; CATHEPSIN E;

ACCURACY; APOPTOSIS; ARTICLE; CANCER CELL; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVATION; HUMAN; HUMAN CELL; INCUBATION TIME; LIGHT IRRADIANCE; PANCREAS ADENOCARCINOMA; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CATHEPSIN E; CELL LINE, TUMOR; HUMANS; LIGHT; MICE; MICE, TRANSGENIC; PANCREATIC NEOPLASMS; PHOTOCHEMOTHERAPY; PRODRUGS;

EID: 84874931140     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.02.007     Document Type: Article

References (31)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 1 2012 10 29
2. C.J. Yeo, J.L. Cameron, T.A. Sohn, K.D. Lillemoe, H.A. Pitt, M.A. Talamini, R.H. Hruban, S.E. Ord, P.K. Sauter, J. Coleman, M.L. Zahurak, L.B. Grochow, and R.A. Abrams Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes Ann. Surg. 226 3 1997 248 257 (discussion 257-260)
3. S.B. Brown, E.A. Brown, and I. Walker The present and future role of photodynamic therapy in cancer treatment Lancet Oncol. 5 8 2004 497 508
4. J.P. Celli, B.Q. Spring, I. Rizvi, C.L. Evans, K.S. Samkoe, S. Verma, B.W. Pogue, and T. Hasan Imaging and photodynamic therapy: mechanisms, monitoring, and optimization Chem. Rev. 110 5 2010 2795 2838
5. D.E. Dolmans, D. Fukumura, and R.K. Jain Photodynamic therapy for cancer Nat. Rev. 3 5 2003 380 387
6. J.F. Lovell, T.W. Liu, J. Chen, and G. Zheng Activatable photosensitizers for imaging and therapy Chem. Rev. 110 5 2010 2839 2857
7. M.C. Issa, and M. Manela-Azulay Photodynamic therapy: a review of the literature and image documentation An. Bras. Dermatol. 85 4 2010 501 511
8. N.S. Nishioka Drug, light, and oxygen: a dynamic combination in the clinic Gastroenterology 114 3 1998 604 606
9. B.G. Fan, and A. Andren-Sandberg Photodynamic therapy for pancreatic cancer Pancreas 34 4 2007 385 389
10. S.M. Hahn, M.E. Putt, J. Metz, D.B. Shin, E. Rickter, C. Menon, D. Smith, E. Glatstein, D.L. Fraker, and T.M. Busch Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy Clin. Cancer Res. 12 18 2006 5464 5470
11. R. Musiol, M. Serda, and J. Polanski Prodrugs in photodynamic anticancer therapy Curr. Pharm. Des. 17 32 2011 3548 3559
12. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.E. Giercksky, and J.M. Nesland 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges Cancer 79 12 1997 2282 2308
13. J.C. Kennedy, R.H. Pottier, and D.C. Pross Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience J. Photochem. Photobiol. 6 1-2 1990 143 148
14. J. Regula, B. Ravi, J. Bedwell, A.J. MacRobert, and S.G. Bown Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer - prolonged animal survival Br. J. Cancer 70 2 1994 248 254
15. C.D. Liu, D. Kwan, R.E. Saxton, and D.W. McFadden Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo J. Surg. Res. 93 1 2000 137 143
16. Q. Xie, L. Jia, Y.H. Liu, and C.G. Wei Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo World J. Gastroenterol. 15 6 2009 737 741
17. S.G. Bown, A.Z. Rogowska, D.E. Whitelaw, W.R. Lees, L.B. Lovat, P. Ripley, L. Jones, P. Wyld, A. Gillams, and A.W. Hatfield Photodynamic therapy for cancer of the pancreas Gut 50 4 2002 549 557
18. T.E. Yusuf, K. Matthes, and W.R. Brugge EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video) Gastrointest. Endosc. 67 6 2008 957 961
19. M. Topazian, N. Zhong, T.H. Baron, S.S. Vege, and K.K. Wang Photodynamic therapy of intraductal papillary mucinous neoplasm Endoscopy 44 2 2012 213 215
20. Z. Cruz-Monserrate, W.R. Abd-Elgaliel, T. Grote, D. Deng, B. Ji, T. Arumugam, H. Wang, C.H. Tung, and C.D. Logsdon Detection of pancreatic cancer tumours and precursor lesions by Cathepsin E activity in mouse models Gut 61 9 2012 1315 1322
21. W.R. Abd-Elgaliel, Z. Cruz-Monserrate, C.D. Logsdon, and C.H. Tung Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe Mol. Biosyst. 7 12 2011 3207 3213
22. W.R. Abd-Elgaliel, and C.H. Tung Selective detection of Cathepsin E proteolytic activity Biochim. Biophys. Acta 1800 9 2010 1002 1008
23. I.P. van Geel, H. Oppelaar, Y.G. Oussoren, J.J. Schuitmaker, and F.A. Stewart Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C Br. J. Cancer 72 2 1995 344 350
24. C. Hopper Photodynamic therapy: a clinical reality in the treatment of cancer Lancet Oncol. 1 2000 212 219
25. Y. Choi, J.R. McCarthy, R. Weissleder, and C.H. Tung Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy ChemMedChem 1 4 2006 458 463
26. C.M. Peterson, J.G. Shiah, Y. Sun, P. Kopeckova, T. Minko, R.C. Straight, and J. Kopecek HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer Adv. Exp. Med. Biol. 519 2003 101 123
27. R.D. Brokx, S.K. Bisland, and J. Gariepy Designing peptide-based scaffolds as drug delivery vehicles J. Control. Release 78 1-3 2002 115 123
28. Y.N. Konan, R. Gurny, and E. Allemann State of the art in the delivery of photosensitizers for photodynamic therapy J. Photochem. Photobiol. 66 2 2002 89 106
29. B. Jang, J.Y. Park, C.H. Tung, I.H. Kim, and Y. Choi Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo ACS Nano 5 2 2011 1086 1094
30. Y. Choi, R. Weissleder, and C.H. Tung Protease-mediated phototoxicity of a polylysine-chlorin(E6) conjugate ChemMedChem 1 7 2006 698 701
31. Y. Choi, R. Weissleder, and C.H. Tung Selective antitumor effect of novel protease-mediated photodynamic agent Cancer Res. 66 14 2006 7225 7229